NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 254 filers reported holding NATERA INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $493,753 | -16.8% | 5,287 | -0.8% | 0.01% | -22.2% |
| Q3 2021 | $593,641 | +1.3% | 5,327 | +3.2% | 0.01% | +12.5% |
| Q2 2021 | $585,815 | -71.5% | 5,160 | -74.6% | 0.01% | -74.2% |
| Q1 2021 | $2,058,927 | -1.4% | 20,277 | -3.4% | 0.03% | 0.0% |
| Q4 2020 | $2,088,527 | +43.1% | 20,986 | +3.8% | 0.03% | +19.2% |
| Q3 2020 | $1,459,970 | +37.7% | 20,210 | -4.9% | 0.03% | +36.8% |
| Q2 2020 | $1,060,024 | +81.8% | 21,260 | +8.9% | 0.02% | +58.3% |
| Q1 2020 | $583,046 | -10.5% | 19,526 | +1.0% | 0.01% | +9.1% |
| Q4 2019 | $651,598 | +7.5% | 19,341 | +4.6% | 0.01% | +10.0% |
| Q3 2019 | $606,406 | +70.8% | 18,488 | +43.6% | 0.01% | +66.7% |
| Q2 2019 | $355,009 | +45.1% | 12,872 | +8.5% | 0.01% | +50.0% |
| Q1 2019 | $244,698 | +47.7% | 11,867 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $165,663 | -37.5% | 11,867 | +7.2% | 0.00% | -40.0% |
| Q3 2018 | $265,040 | -99.9% | 11,071 | 0.0% | 0.01% | +66.7% |
| Q2 2018 | $208,356,000 | +103.0% | 11,071 | 0.0% | 0.00% | +200.0% |
| Q1 2018 | $102,628,000 | +102528.0% | 11,071 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $100,000 | -62.1% | 11,071 | -45.9% | 0.00% | -50.0% |
| Q3 2017 | $264,000 | +18.9% | 20,455 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $222,000 | +22.7% | 20,455 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $181,000 | -24.6% | 20,455 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $240,000 | +5.7% | 20,455 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $227,000 | -8.1% | 20,455 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $247,000 | – | 20,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |